Is a combination of 2 mg Midazolam, 25 mg Ketamine, 100 mcg Fentanyl, 30 mg Propofol, and 50 mg Rocuronium (Rocuronium) sufficient for intubation anesthesia in a 40-year-old, 50 kg patient with cardiovascular disease and poor cardiovascular reserve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthetic Regimen Assessment for Intubation in Cardiovascular Disease

The current combination of drugs (2 mg Midazolam, 25 mg Ketamine, 100 mcg Fentanyl, 30 mg Propofol, and 50 mg Rocuronium) is insufficient for safe and effective intubation in a 40-year-old, 50 kg patient with cardiovascular disease and poor cardiovascular reserve.

Dosage Analysis

  • The Rocuronium dose of 50 mg (1.0 mg/kg) is at the lower end of the recommended range for rapid sequence intubation, which should be 1.0-1.2 mg/kg (50-60 mg for this patient) to ensure optimal intubating conditions 1, 2
  • The Ketamine dose of 25 mg (0.5 mg/kg) is below the recommended range of 1-2 mg/kg IV (50-100 mg for this patient) for patients with cardiovascular disease 1, 3
  • The Propofol dose of 30 mg (0.6 mg/kg) is significantly lower than the recommended induction dose of 1.5-2.5 mg/kg, but this reduced dose is appropriate given the patient's cardiovascular disease 4, 5
  • The Midazolam dose of 2 mg is within the recommended range for premedication 6, 7
  • The Fentanyl dose of 100 mcg (2 mcg/kg) is at the lower end of the recommended range for suppressing laryngeal reflexes during intubation 1, 3

Hemodynamic Considerations

  • In patients with cardiovascular disease and poor reserve, hemodynamic stability during induction and intubation is crucial 1, 3
  • Ketamine provides relative hemodynamic stability through its sympathomimetic effects, which is beneficial in patients with cardiovascular compromise 1, 3
  • The combination of ketamine with midazolam can effectively attenuate the cardiostimulatory responses while maintaining hemodynamic stability 3, 7
  • Propofol causes a decrease in blood pressure secondary to decreases in preload and afterload, which can be problematic in patients with poor cardiovascular reserve 4

Neuromuscular Blockade Assessment

  • For rapid sequence intubation, Rocuronium should be administered at 1.0-1.2 mg/kg to ensure optimal intubating conditions 1, 2
  • Studies show that after induction with fentanyl and propofol, rocuronium at 1.04 mg/kg gives a 95% probability of successful intubation at 60 seconds 8
  • Insufficient neuromuscular blockade increases the risk of coughing, bucking, and hemodynamic instability during intubation, which is particularly dangerous in a patient with poor cardiovascular reserve 1

Recommended Modifications

  • Increase the Ketamine dose to 50 mg (1.0 mg/kg) to provide better hemodynamic stability 1, 3
  • Consider increasing the Fentanyl dose to 150-200 mcg (3-4 mcg/kg) to better blunt the sympathetic response to intubation 3, 5
  • The current Rocuronium dose of 50 mg (1.0 mg/kg) is at the minimum recommended dose for rapid sequence intubation; consider increasing to 60 mg (1.2 mg/kg) for more reliable intubating conditions 1, 2, 8

Potential Pitfalls and Considerations

  • Patients with cardiovascular disease may have depleted catecholamine stores, potentially limiting Ketamine's sympathomimetic effects and increasing the risk of hypotension 1
  • The combination of benzodiazepines and opioids increases the risk of respiratory depression, requiring careful monitoring 6
  • Ensure vasopressors are immediately available to manage potential hypotension during induction 1, 4
  • For patients with coronary artery disease, the combination of ketamine, midazolam, and fentanyl has been shown to provide better hemodynamic stability during induction compared to propofol-based regimens 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.